Citadel Advisors’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,024
| Closed | -$74.7K | – | 6988 |
|
|
2023
Q4 | $74.7K | Buy |
+10,024
| New | +$74.7K | ﹤0.01% | 4976 |
|
|
2023
Q3 | – | Sell |
-2,592
| Closed | -$18.7K | – | 6690 |
|
|
2023
Q2 | $18.7K | Buy |
+2,592
| New | +$18.7K | ﹤0.01% | 5272 |
|
|
2023
Q1 | – | Sell |
-6,337
| Closed | -$42.3K | – | 6729 |
|
|
2022
Q4 | $42.3K | Buy |
+6,337
| New | +$42.3K | ﹤0.01% | 5331 |
|
|
2022
Q3 | – | Sell |
-2,816
| Closed | -$34K | – | 6899 |
|
|
2022
Q2 | $34K | Buy |
+2,816
| New | +$34K | ﹤0.01% | 5609 |
|
|
2022
Q1 | – | Sell |
-2,314
| Closed | -$139K | – | 7299 |
|
|
2021
Q4 | $139K | Buy |
2,314
+571
| +33% | +$34.3K | ﹤0.01% | 5720 |
|
|
2021
Q3 | $163K | Buy |
+1,743
| New | +$163K | ﹤0.01% | 5552 |
|